Zu "1714088-51-3" wurden 2 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Telisotuzumab vedotin
Artikelnummer: TGM-T77838-5mg
Description: Telisotuzumab vedotin (ABBV-399), an antibody-drug conjugate (ADCs), targets c-Met and comprises the cytotoxic agent Monomethyl Auristatin E (MMAE), the Telisotuzumab antibody, and a cleavable mc-val-cit-PABC linker. This compound is utilized in cancer research [1]. Target: Others, Antibody-Drug...
| Schlagworte: | ABBV-399 |
| Anwendung: | Targets proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1] (MET, HGFR) |
| CAS | 1714088-51-3 |
558,00 €
Telisotuzumab Vedotin
Artikelnummer: BPS-82922-1
Telisotuzumab vedotin (ABBV-399) is an antibody-drug conjugate (ADCs) targeting c-Met. Telisotuzumab vedotin consists of Monomethyl Auristatin E (MMAE), Telisotuzumab antibody and a cleavable mc-val-cit-PABC type linker. Telisotuzumab vedotin can be used to study non-small cell lung cancer expressing c-Met protein1,2.
| Schlagworte: | Anti-MET, Anti-SF receptor, EC=2.7.10.1, Anti-HGF receptor, Anti-HGF/SF receptor, Anti-Proto-oncogene c-Met, Anti-Scatter... |
| Anwendung: | Cancer therapy target studies |
| Spezies-Reaktivität: | human |
| CAS | 1714088-51-3 |
| MW: | ~145 kD |
ab 805,00 €
